FIT PATIENTS

Clinical trials for FIT PATIENTS explained in plain language.

Never miss a new study

Get alerted when new FIT PATIENTS trials appear

Sign up with your email to follow new studies for FIT PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug combo challenges chemo for Intermediate-Risk CLL

Disease control Completed

This study tested whether a combination of two targeted drugs (venetoclax and ibrutinib) works better than standard chemotherapy (FCR) for people with intermediate-risk chronic lymphocytic leukemia (CLL) who have not been treated before. About 120 fit adults took part. The treatm…

Matched conditions: FIT PATIENTS

Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

FIT PATIENTS

Get alerted when new FIT PATIENTS trials appear

New drug combo challenges chemo for Intermediate-Risk CLL